安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- American Society of Clinical Oncology - ASCO
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy in previously untreated advanced squamous non–small cell lung cancer: Overall survival results of the phase 3 HARMONi-6 trial
- ASCO Publications
Through research, education, and promotion of the highest-quality, equitable patient care, ASCO works to conquer cancer and create a world where cancer is prevented or cured, and every survivor is healthy
- ASCO 2026 Annual Meeting: Dates, Location, Program Overview
A Leading Global Meeting in Oncology Join the global oncology community May 29–June 2, 2026, at McCormick Place in Chicago, Illinois, with additional online access available The American Society of Clinical Oncology (ASCO) Annual Meeting is one of the most influential gatherings in cancer care, bringing together clinicians, researchers, and healthcare professionals to explore the latest
- ASCO | Valve and Fluid Control Solutions - Emerson
Wherever manufacturing or fluid processing occurs, ASCO fluid automation solutions maximize customer efficiencies, optimize applications and improve safety ASCO’s broad offerings in fluid control solutions integrate with hundreds of process, industrial, analytical and medical applications
- ASCO 2026 || American Society of Clinical Oncology
ASCO offers premier scientific events for oncology professionals, patient advocates, industry representatives, and major media outlets worldwide The ASCO 2026 meeting is the premier event for strategies to improve quality care in oncology
- Top Immunotherapy Trials to Watch at ASCO 2026 - OncoDaily
A curated preview of the most important immunotherapy trials to watch at the ASCO 2026 Annual Meeting, highlighting innovative strategies across melanoma, urothelial, pancreatic, and HPV-associated cancers
- ASCO Annual Meeting - ASCO
Preview more than 3,400 abstracts to be presented featuring high-impact oncology data that will drive advancements and inspire new solutions to improve outcomes for all people with cancer The ASCO Annual Meeting is more than a conference—it’s the place to be a part of something bigger
- ASCO 2026 preview – recent wins come under the spotlight
Several high-profile clinical trials are set to come under the spotlight in late-breaking presentations at the ASCO conference, after being toplined as positive by their developers in recent weeks These include AstraZeneca’s Emerald-3 liver cancer study, which has shown a PFS benefit for one of its Imfinzi Imjudo cohorts, and the Successor-2 trial of Bristol Myers Squibb’s Pomalyst follow
|
|
|